230 related articles for article (PubMed ID: 21247530)
1. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
[TBL] [Abstract][Full Text] [Related]
2. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
4. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
5. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of plasma renin activity in heart failure.
Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
10. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
11. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.
Adlbrecht C; Hülsmann M; Neuhold S; Strunk G; Pacher R
J Heart Lung Transplant; 2013 May; 32(5):533-8. PubMed ID: 23453573
[TBL] [Abstract][Full Text] [Related]
13. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
[TBL] [Abstract][Full Text] [Related]
18. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
19. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
